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segmentation method that uses Dirichlet process priors to 
classify the images (code dpmixsim implemented in R, R 
Foundation for Statistical Computing, Vienna, Austria). The 
DP mixture model is a Bayesian method based on Markov 
chain Monte Carlo simulations for exploring mixture models 
with an unknown number of components, not specified in 
advance. It depends on 4 parameters (M for precision of the 
DP; a and b related to prior distribution; minvar for the 
minimum value admissible for a cluster variance). We 
repeated contour generation on the bigger sphere of the IEC 
phantom by setting the DP parameters to different values 
and we performed an anova test to verify their ability to 
reproduce the true radius of the sphere. Once the optimal 
parameter set was found, we applied the proposed algorithm 
to the whole dataset. Volumes obtained by the DP algorithm 
were compared to the true values of the IEC spheres and of 
the digital phantom, and to the volumes retrospectively 
segmented by an experienced radiation oncologist for the 20 
clinical cases. 
Results: The only parameter that influenced lesion 
segmentation was minvar, that depended almost linearly on 
the standard deviation of the voxel values in the region of 
interest. The parameters used for the analysis were: M=1; 
a=1; b=0; minvar optimized based on σROI. The agreement 
between the reference volumes and the result of the 
segmentation was within 5% for the spherical phantom and 
within 10% for the digital phantom and the clinical cases. 
Conclusions: The described procedure allowed a robust, 
automatic segmentation of PET volumes to be performed that 
accurately described reference values. This might form the 
basis for clinical implementation of the algorithm.  
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Purpose/Objective: Recently there has been considerable 
clinical interest in the use of MRI to delineate gross target 
volumes (GTV) and organs at risk (OAR) for head and neck 
squamous cell carcinoma (HNSCC). A gold standard (GS) for 
delineation is considered to be delineation using a dedicated 
treatment position MRI (MRI-RT) rigidly registered to the 
planning CT scan, although the MRI-RT is not widely available 
in many centres. This study aimed to assess whether 
deformable image registration (DIR) of a diagnostic position 
MRI (MRI-D) to the planning CT scan is an adequate surrogate 
for the GS.  
Materials and Methods: A prospective pilot imaging study 
was performed with 3 HNSCC patients (oropharynx, larynx 
and hypopharynx cancers) who underwent contrast enhanced 
CT and T1 weighted MRI both in (MRI-RT) and out of (MRI-D) 
an immobilisation mask. A Radiation Oncologist delineated 
GTV and OARs (see Table 1) on CT, MRI-RT and MRI-D 
independently each on 3 separate occasions. Contour 
comparison (parameters shown in Table 1) was performed 
with ImSimQA v3.1.5 (OSL, Shrewsbury UK) to assess intra-
observer variability of contouring on each imaging modality. 
Consensus contours from the 3 delineations were produced 
using a form of majority vote. GS structures were defined as 
consensus contours from MRI-I transposed to CT using rigid 
registration (simulating radiotherapy departments with a 
dedicated MRI scanner). The GS was compared to contours 
produced by 2 other methods: MRI-D transposed to CT with 
DIR (simulating radiotherapy departments without a 
dedicated MRI scanner); and CT alone delineations 
(simulating radiotherapy departments with no MRI access). 
All registrations were performed using Mirada RTx v1.4 
(Mirada Medical, Oxford UK).  
Results: Contouring on MRI (MRI-RT or MRI-D) reduced intra-
observer variability compared to CT (Dice similarity 
coefficient (DSC) range 0.82-0.99 for MRI and 0.76-0.85 for 
CT, Table 1). Contouring on CT alone is less accurate than 
the GS, with particularly limited accuracy compared with the 
GS for GTV and cord. Delineating on MRI-D and using DIR to 
transpose contours onto the planning CT appears superior to 
delineation on CT alone for GTV (DSC 0.78 versus 0.5); there 




Conclusions: Reproducibility of contouring with MRI was 
found to be better than with CT indicating that the addition 
of MRI to the workflow for HNSCC patients is preferable. 
Contouring on MRI-RT was more accurate than contouring on 
CT or MRI-D and therefore a preferable workflow. However, 
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in the absence of dedicated MRI scanners commercial DIR 
software can facilitate MRI-D into treatment protocols with a 
benefit in accuracy for GTV delineation demonstrated in this 
study. Use of MRI-D was limited by the reduced accuracy of 
DIR with increasing distance from the GTV. 
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Purpose/Objective: The aim of this study was to evaluate 
changes and artefact reduction and streaking index (SI) for 
liquid and solid fiducial markers in both single energy CT 
(SECT) and dual energy CT (DECT) with different metal 
artefact reduction (MAR) algorithms on a clinical CT-scanner. 
The artefacts were quantified by severity and SI on SECT and 
DECT with the eight different MAR algorithms and with no 
MAR. 
Materials and Methods: A total of 16 markers were 
evaluated, two liquid markers (BioXmark and Lipiodol) with 
varying volumes (10 to 400 μL) and five solid marker 
(PolyMark, BeamMarks, FusionCoil, Gold Anchor and a solid 
gold marker). Each marker was moulded into gelatine in a 
hollow low density polyethylene rod container with a 
diameter of 2.5 cm. Imaging was performed with the filled 
rod container placed inside a CIRS IMRT thorax phantom to 
represent a lung tumour with a fiducial marker inserted.SECT 
and DECT-images were acquired for each marker inside their 
respective container inside the thorax phantom, additionally 
SECT and DECT images were acquired with gelatine filled 
container but with no marker to serve as a background. SECT 
images were acquired at 120 kVp, DECT-images were 
acquired at 80 kV and 140 kV, and further combined to 
represent a mono-energetic image at 70 keV. Tube current 
was selected so that both the SECT and the DECT scans would 
result in the same dose to the phantom, Slice thickness was 2 
mm. A total of eight MAR reconstruction algorithms and one 
reconstruction without MAR were evaluated for both SECT 
and DECT. The software used on the CT scanner was a clinical 
evaluation version with the MAR functionality installed.  
Results: For the liquid markers, the artefact analysis showed 
that the SI increased as a function of marker size (volume) in 
the absence of MAR. The reduction of the SI for the BioXmark 
worked best for the larger markers (100 to 400 μL) (Table 1). 
The SI was highest for the two gold markers when no MAR 
algorithm was used. The MAR algorithm reduces the SI most 
when the 'neuro' MAR algorithm was used for both SECT and 




Conclusions: We quantified the SI and artefact severity for a 
series of both liquid and solid fiducial markers implanted in a 
simulated tumour in a thorax phantom. We showed that the 
MAR algorithms reduced both the SI and the artefact severity 
in both SECT and DECT for all markers but was better on the 
larger markers (100-400 μL) and the markers with pure gold 
(Gold Anchor and gold marker). Additional evaluation of the 
artefact reductions effect on dose distribution in both photon 
and proton planning is needed  
 
PO-0965   
Deep inspiration breath-hold in left-sided breast 
radiotherapy or not?: decision based on a single CT-slice 
S. Petillion1, K. Verhoeven1, F. Van den Heuvel2, C. Weltens1 
1University Hospital Gasthuisberg, Radiation-Oncology, 
Leuven, Belgium  
2University of Oxford, Gray Institute for Radiation Oncology 
and Biology, Oxford, United Kingdom  
 
Purpose/Objective: The mean heart dose (MHD) difference 
between deep inspiration breath-hold (DIBH) and free-
breathing (FB) left-sided whole breast radiotherapy (WBRT) is 
small for a subgroup of patients. Decision-making on FB or 
DIBH during treatment planning requires the delineation of 
the regions of interest on the FB and DIBH CT-scans. This 
doubles the workload. This study therefore explored the 
feasibility of DIBH decision-making based on a single CT-slice, 
acquired prior to full CT acquisition. 
Materials and Methods: For 30 left-sided patients treated 
with tangential field FB-WBRT, the MHDs were calculated. 
Per patient, 2 FB CT-slices were selected. On each, 2 
distances were measured with respect to the individual field 
setup (Figure): the maximum heart width and the maximum 
heart length at half the height of the breast volume 
(MHWBreast and MHLBreast, respectively), MHW and MHL on the 
CT-slice visualizing the smallest distance between the heart 
silhouette and the ribs (MHWHeart and MHLHeart, respectively). 
The (distance,CT-slice)-combination revealing the strongest 
linear correlation with the MHD was retained as MHD 
surrogate (S). For DIBH decision-making, a clinically relevant 
MHD threshold of 3.5 Gy was considered. The corresponding 
threshold of S (SThreshold) was determined by the Youden index: 
